(CNSX: CBDN) (OTC: CBDN) (Frankfurt:GS3)
Growth Through Innovation
CBD Global Sciences is an American multi-national consumer goods and farming company headquartered in Denver, Colorado, founded by American entrepreneurs Brad Wyatt and Glenn Dooley. It specializes in a wide range of CBD products and the cultivation of hemp plants. In 2015, co-founders Brad and Glenn recognized the growing demand for hemp and quickly became one of the leading hemp-farming companies in Colorado. The Company's President and CEO, Brad Wyatt, said, “the future of Cannabidiol products start from the seed and it doesn’t end for us until we’ve packaged the product to sell.”
Today, we are working to build a growing and profitable company. Our goal is clear—meeting the needs of consumers better than our competitors to deliver shareholder value. We are doing this by concentrating on developing a strong leadership team, leading in innovative Cannabidiol (CBD) products, ensuring ethical quality management and control, creating protective legal and regulatory guidelines globally, setting new standards of quality, bringing a productivity mindset, and inspiring our people to keep the consumer at the center of everything we do.
Key Investment Considerations
From 2018 to 2019 CBD Global Sciences saw an increase of 290% in revenue.
Well-established distribution network with 85 small to major US Airports and over 600 retail stores.
Strasburg Pharms, a wholly owned subsidiary, has acquired approx. 179 contiguous acres of farmable land through lease and purchase.
The “Cowen’s Collective View of CBD” report states that they believe US CBD could conservatively generate sales of $16 billion by 2025.
Latest News
CBD Global Sciences Commences Full-Scale Production and Secures First Purchase Orders for its Newly Launched CBD Infused Gummy Products
©2020 CBDGLOBALSCIENCES.COM All Rights Reserved.
Sign up for updates
Growth Through Innovation
CBD Global Sciences is an American multi-national consumer goods and farming company headquartered in Denver, Colorado, founded by American entrepreneurs Brad Wyatt and Glenn Dooley. It specializes in a wide range of CBD products and the cultivation of hemp plants. In 2015, co-founders Brad and Glenn recognized the growing demand for hemp and quickly became one of the leading hemp-farming companies in Colorado. The Company's President and CEO, Brad Wyatt, said, “the future of Cannabidiol products start from the seed and it doesn’t end for us until we’ve packaged the product to sell.”
Today, we are working to build a growing and profitable company. Our goal is clear—meeting the needs of consumers better than our competitors to deliver shareholder value. We are doing this by concentrating on developing a strong leadership team, leading in innovative Cannabidiol (CBD) products, ensuring ethical quality management and control, creating protective legal and regulatory guidelines globally, setting new standards of quality, bringing a productivity mindset, and inspiring our people to keep the consumer at the center of everything we do.
(CNSX: CBDN)
(OTC: CBDN)
(Frankfurt:GS3)